Cell Harvesting Systems Market: Applications, End Users, Regions, and Competitive Dynamics
Applications, end users, and regional dynamics offer a practical lens on the cell harvesting systems market. Polaris Market Research reports a 2024 value of USD 6.02 billion, rising from USD 6.87 billion in 2025 to a projected USD 22.98 billion by 2034, at a CAGR of 14.3% from 2025 to 2034.
Bone Marrow Leads by Application
By application, the market is segmented into bone marrow, umbilical cord, adipose tissue, and peripheral blood. The bone marrow segment dominated in 2024, driven by its critical role in hematopoietic stem cell transplantation for treating blood-related disorders such as leukemia, lymphoma, and aplastic anemia.
The report adds that bone marrow cells are a cornerstone in regenerative medicine and oncology, with increasing adoption of cell-based therapies globally. It cites the Center for International Blood and Marrow Transplant Research as indicating that approximately 50,000 allogeneic and autologous transplants are performed annually worldwide, emphasizing the need for efficient harvesting technologies tailored to this application.
Cord Blood Stem Cells and the Fastest-Growing Application
The umbilical cord segment is projected to experience the fastest growth during the forecast period, owing to rising use of cord blood stem cells in therapeutic and regenerative applications. Umbilical cord blood is a rich source of hematopoietic stem cells, and its collection is minimally invasive, making it increasingly preferred for cell-based treatments.
The growing establishment of cord blood banks and advances in cryopreservation technologies are further driving expansion. The report cites the American Academy of Pediatrics as noting that over 80 diseases, including genetic, hematologic, and immunologic disorders, can be treated using cord blood stem cells.
Biopharmaceutical Companies Hold the Largest End-User Share
By end user, the market is segmented into research centers, biotechnology and biopharmaceutical companies, diagnostic labs, and others. Biotechnology and biopharmaceutical companies held the largest revenue share in 2024, driven by extensive use of harvesting technologies in drug development, biopharmaceutical production, and cell-based therapy manufacturing.
These biopharmaceutical companies are increasingly investing in advanced systems to ensure high-quality cell recovery and compliance with regulatory standards in clinical and commercial production.
Research Centers Show the Highest Growth Rate
The research centers segment is anticipated to register the highest growth rate during the projection period, fueled by the expansion of cell biology and regenerative medicine research. Increasing focus on novel therapeutic applications of stem cells and immune cells is contributing to demand in academic and research institutions.
Government funding and private investment in scientific research are also fostering growth among research centers. The report notes that the National Institutes of Health allocated over USD 2 billion to stem cell research funding in 2023.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :
https://www.polarismarketresearch.com/industry-analysis/cell-harvesting-systems-market
Regional Perspective
North America held the largest market share in 2024, attributed to well-established biotechnology and biopharmaceutical industries, robust healthcare infrastructure, and extensive research and development funding. The report also cites the 21st Century Cures Act and increased investment in regenerative medicine and stem cell research as contributors.
Europe plays a key role, with Germany, the United Kingdom, and France leading contributors and Horizon Europe funding supporting stem cell and regenerative medicine research. The Asia Pacific market is projected to witness rapid growth, led by China, Japan, and India, supported by expanding healthcare infrastructure, rising prevalence of chronic diseases, increasing medical tourism, and the establishment of stem cell banks.
Competitive Landscape and Key Players
Competition is characterized by technological innovation, with companies developing automated and closed-system solutions to improve cell yield and minimize contamination. Strategic partnerships and regional expansion toward high-growth regions such as Asia Pacific are also prevalent. Miltenyi Biotec is regarded for magnetic cell sorting technologies, while Thermo Fisher Scientific offers platforms integrating harvesting and processing.
Key players named in the report include PerkinElmer, Inc.; Danaher Corporation; Becton, Dickinson and Company; Thermo Fisher Scientific, Inc.; GE HealthCare Technologies, Inc.; Terumo Corporation; STEMCELL Technologies Inc.; Miltenyi Biotec; Corning Incorporated; Merck KGaA; Lonza Group AG; PromoCell GmbH; Bio-Rad Laboratories, Inc.; Nikon Corporation (Healthcare Business Unit); and Charles River Laboratories International, Inc.
Conclusion
The cell harvesting systems market is poised for growth due to increasing demand for advanced cell-based research and biopharmaceutical production. The expansion of regenerative medicine, cell therapy, and tissue engineering is creating new opportunities for specialized harvesting technologies. Pharmaceutical and biotechnology companies are investing in systems that improve cell recovery, viability, and processing efficiency. Automation and closed-system technologies are also helping reduce contamination risks and support consistent results. Continued progress in biomedical research is expected to strengthen demand for advanced cell harvesting solutions. Overall, the market outlook remains promising as cell-based therapies and biomanufacturing continue to advance.
More Trending Latest Reports By Polaris Market Research:
Cell & Gene Therapy Bioanalytical Testing Services Market
Restaurant Point-Of-Sale (Pos) Terminals Market
Major Innovations in the Electric Scooter to Positively Influence the Global Industry